Mini Review ARTICLE
Versatile Structures of α-Synuclein
- 1Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China
- 2Department of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH, USA
- 3Center for Mitochondrial Biology and Medicine, Key Laboratory of Biomedical Information Engineering of Ministry of the Education School of Life Science, Xi’an Jiaotong University, Xi’an, China
- 4Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA, USA
α-Synuclein (α-syn) is an intrinsically disordered protein abundantly distributed in presynaptic terminals. Aggregation of α-syn into Lewy bodies (LB) is a molecular hallmark of Parkinson’s disease (PD). α-Syn features an extreme conformational diversity, which adapts to different conditions and fulfills versatile functions. However, the molecular mechanism of α-syn transformation and the relation between different structural species and their functional and pathogenic roles in neuronal activities and PD remain unknown. In this mini-review, we summarize the recent discoveries of α-syn structures in the membrane-bound state, in cytosol, and in the amyloid state under physiological and pathological conditions. From the current knowledge on different structural species of α-syn, we intend to find a clue about its function and toxicity in normal neurons and under disease conditions, which could shed light on the PD pathogenesis.
Abnormal aggregation of α-synuclein (α-syn) is closely associated with Parkinson’s disease (PD). The aggregated α-syn was found dominantly in Lewy bodies (LB) as the hallmark of PD (Spillantini et al., 1997) and other syncleinopathies such as dementia with LB, and multiple system atrophy. α-Syn also co-aggregates with amyloid β (Aβ) in the brain tissue of patients diagnosed as Alzheimer’s disease (AD; Uéda et al., 1993). Various point mutations of gene SNCA (encoding α-syn), and the duplication and triplication of α-syn locus all lead to dominant familial PD (Polymeropoulos et al., 1997; Krüger et al., 1998; Singleton et al., 2003; Chartier-Harlin et al., 2004; Zarranz et al., 2004; Mizuno et al., 2012; Lesage et al., 2013; Proukakis et al., 2013; Pasanen et al., 2014; Ferese et al., 2015). Despite its crucial role in pathogenesis, α-syn is believed to perform biological functions under physiological conditions because of its extremely high abundance in primary neurons, representing 1% of the total protein (Mizuno et al., 2012). It mainly gathers in presynaptic terminals and associates with reserve pool of synaptic vesicles (Maroteaux et al., 1988; Larsen et al., 2006; Nemani et al., 2010). α-Syn is capable of clustering synaptic vesicles and facilitating the assembly of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex (Burré et al., 2010). Corresponding to its diverse roles under both physiological and pathological conditions, various forms of α-syn, such as monomer, oligomer, and fibril, were found in cytosol, on membrane, and in the amyloid aggregation states (Iwai et al., 1995; Burré et al., 2014; Theillet et al., 2016). Therefore, to reveal the structural variations of α-syn is of great importance to understand its physiological function and pathogenic property.
α-Syn is an intrinsically disordered protein. It consists of 140 amino acids and is divided into three regions (Figure 1A). Each region has distinct physiochemical property corresponding to the amino acid composition. The N-terminal region (residues 1–60) is capable of forming an amphipathic helix which is a typical conformation for membrane recognition and association (Segrest et al., 1990; Jao et al., 2008). Several mutations found in familial PD, such as A53T (Polymeropoulos et al., 1997), E46K (Zarranz et al., 2004), and A30P (Krüger et al., 1998), are located in this region, indicating the importance of membrane binding for the function of α-syn. The central region containing residues 61–95 is well known as the non-amyloid β component (NAC) firstly identified in AD senile plaques (Uéda et al., 1993). This region features a high propensity to form a β-rich conformation and is highly aggregation-prone (Uversky et al., 2001). Different types of post-translational modifications within this region show distinct effects on modulating α-syn aggregation. For example, glycosylation at T72 and phosphorylation at S87 have been reported to block α-syn aggregation (Paleologou et al., 2014; Marotta et al., 2015). The C-terminal region with residues 96–140 is rich of proline and negatively charged residues including 10 glutamates and five aspartates, which is a common characteristic found in intrinsically disordered proteins to maintaining solubility. On the structural front, several important questions remain unclear. How do the three regions independently and cooperatively accomplish the formation and conversion of α-syn structures in different states? What are the common structural features of α-syn in different states? How to correlate the biological function and cellular toxicity of α-syn with the different structures or structural transformation? Regarding these important fundamental questions, we summarize the current knowledge of α-syn structures in the states of membrane binding, cytosol, and amyloid aggregation. We also discuss the relationship between the different structural states and their physiological function and pathological toxicity.
Figure 1. Structural models of α-synuclein (α-syn) in different states. (A) The primary sequence of α-syn with three regions highlighted in blue, orange and red, respectively. The three familial Parkinson’s disease (PD)-related mutations are denoted. (B) The structural model of an α-syn monomer on unilamellar vesicles (from Jao et al., 2008 reprinted with permission). The continuing helix (residues 9–89) is colored in green. (C) The helical wheel model of α-syn membrane-binding region from residue 9 to 90. (D) The structure of a micelle-bound α-syn monomer (Protein Data Bank ID: 1XQ8). The three regions are color-coded according to (A). (E) The geometry and arrangement of a single layer of fibril core from three α-syn fibrillar models in cartoon form (Vilar et al., 2008; Dearborn et al., 2015; Rodriguez et al., 2015) viewed perpendicular to the fibril axis. The top and bottom ones both contain single α-syn monomer per layer of protofilament. The middle one contains two α-syn monomers paired via steric-zipper-like interaction. The different regions are color-coded according to (A). (F) The atomic structure of α-syn non-amyloid β component (NAC) fibril core obtained from electron diffraction (Protein Data Bank ID: 4RIL). (G) The structural model of an α-syn fibril determined by solid-state nuclear magnetic resonance (NMR; Protein Data Bank ID: 2N0A). The three regions are color-coded according to (A). The side chains of the fibril core (residues 46–54 and 63–96) are shown in stick representation. (H) The architecture of an α-syn oligomer formed in the presence of supported lipid bilayers probed by atomic force microscopy (AFM; from Quist et al., 2005 reprinted with permission). (I) The structural model of two types of soluble α-syn oligomers (upper for 10S and bottom for 15S oligomer subgroups) measured by cryoEM (from Chen et al., 2015 reprinted with permission).
The Structure of Membrane-Bound α-Syn
α-Syn is capable of binding to membrane upon the structural transition from random coil to α-helix (Davidson et al., 1998). The N-terminal region of α-syn contains seven copies of a tandem 11-residue pseudorepeat, which is a characteristic of lipid-binding domains found in apolipoproteins (George et al., 1995). By using electron paramagnetic resonance (EPR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy, α-syn was found to adopt a continuous helix from residue 9–89 on the surface of unilamellar vesicles (Figure 1B; Jao et al., 2008; Bodner et al., 2009). As shown in the helical wheel (Figure 1C), the helix features four interfaces with distinct properties. The interface in pink is mainly composed of hydrophobic residues and is buried inside the membrane. The green interface containing several Glu residues is exposed to the solvent. Meanwhile, the two white colored strips on the two sides of the helix feature 11 positively charged Lys residues which correspond to the electrostatic interaction with the head groups of lipids. Indeed, it was reported that α-syn only recognizes and binds to the membrane composed of phospholipids with negatively charged head groups such as PS and PA (Eliezer et al., 2001; Jain et al., 2013).
A recent work shows that, upon membrane recognizing and binding, the first 25 amino acids are involved in a well-defined helical structure acting as a membrane anchor to initiate docking of α-syn on the membrane (Fusco et al., 2014). Meanwhile, the rest of the helix (residues 26–97) exhibits a structural flexibility, and transforms between helix and random coil depending on the lipid composition (Fusco et al., 2014). This region is believed to determine the binding affinity of α-syn to membrane. Upon binding to a highly curved membrane surface, the continuous helix breaks into two individual helices (Rao et al., 2010). The structure of α-syn bound to sodium dodecyl sulfate (SDS) micelles was determined by using solution NMR (Ulmer et al., 2005). Unlike the continuous helical structure found in the liposome-bound state, SDS-bound α-syn forms two slightly curved α-helices (residues 3–37 and 45–92) exhibiting a hairpin structure connected by a stretched five-residue linker (Figure 1D). The circle diameters of the two curved α-helices are ~153 Å and ~82 Å, respectively, which are much smaller than that of presynaptic vesicles (~400–500 Å). No direct interactions were observed between the two helices. Molecular dynamics (MD) simulations show that, depending on the curvature and property of the membrane surface, α-syn senses and adapts to membrane by adjusting the circle diameters and the relative positions of the two helices (Drescher et al., 2008; Ferreon et al., 2009; Lokappa and Ulmer, 2011; Robotta et al., 2011). In the membrane-bound state, the C-terminal region is highly flexible with no association to the membrane. In addition, a recent study indicated that α-syn forms a multimer on the membrane by using fluorescence resonance energy transfer (FRET) and chemical cross-linking (Burré et al., 2014). However, the atomic structural information of this multimer is absent.
The Function of α-Syn in Synaptic Transmission
Studies have suggested that α-syn functions in various aspects of synaptic transmission. Burré et al. (2010) have found that α-syn can facilitate neuronal SNARE complex assembly, which is fulfilled by the direct interaction between the highly flexible and negatively charged C-terminal region of α-syn and the N-terminus of synaptobrevin-2/VAMP2 (vesicle associated membrane protein 2; Burré et al., 2010). Synaptobrevin-2/VAMP2 is a key component of SNARE complex residing on the synaptic vesicles. Membrane anchoring of α-syn via its N-terminal region is also essential for the process. The same group has also hypothesized that, in compensation for cysteine string protein α (CSPα), α-syn can act as a neuroprotective chaperone to maintaining the SNARE function (Chandra et al., 2005).
Complementary to the in vivo studies, in vitro assays involving protein-reconstituted vesicles were performed to investigate the function of α-syn in synaptic transmission (Brunger et al., 2015). Diao et al. (2013) showed that α-syn significantly promotes the clustering of protein-reconstituted liposomes—minimal mimics of synaptic vesicles, while with little effect on Ca2+-triggered fusion in a single vesicle-vesicle system with reconstituted neuronal SNAREs, synaptotagmin-1, and complexin-1. The function of vesicle-clustering was observed for both recombinant as well as native α-syn purified from mouse brains, and was confirmed by in vivo studies (Wang et al., 2014). The clustering of synaptic vesicles by α-syn could promote the neuronal trans-SNARE complex formation and provide a “buffer” of synaptic vesicles for synaptic transmission.
α-Syn was also found to reduce ensemble lipid mixing (Dewitt and Rhoades, 2013). Through advanced single vesicle technique, others found that α-syn reduces the ensemble lipid mixing by blocking vesicle association (Choi et al., 2013; Lai et al., 2014). α-Syn was also shown to jam the synaptic vesicle trafficking on the “priming” step (Larsen et al., 2006). Overexpression of α-syn in chromaffin cells resulted in the accumulation of docked vesicles without being secreted (Larsen et al., 2006). Another study showed that α-syn impairs the re-clustering of synaptic vesicles on the vesicle recycling step after endocytosis in the rodent hippocampus (Nemani et al., 2010). Therefore, α-syn can play multiple roles throughout the process of synaptic vesicle trafficking, including vesicle clustering, priming, fusion (assembly of SNARE complex), and recycling (disassembly of SNARE complex; Lashuel et al., 2013).
These functions of α-syn are all associated with membrane binding, while the structural information of membrane-bound α-syn described in the early section is too limited to explain the underling mechanism. However, the versatile functions may reflect a dynamic conformational transition of α-syn possibly combined with an association and dissociation of α-syn multimers upon interacting with membranes. Therefore, it is reasonable to deduce that α-syn is regulated by some unidentified cofactors to ensure proper structural conformations, cellular localization, and local concentration upon membrane binding and release. The failure of regulation might result in dysfunction of α-syn and amyloid aggregation.
α-Syn in Cytosol Under Physiological Conditions
Although α-syn exhibits a strong membrane-binding capability, accumulating evidence show that α-syn dominantly exists in cytosol instead (Binolfi et al., 2012; Fauvet et al., 2012; Theillet et al., 2016). However, studies of α-syn in cytosol gained conflicting results. Recombinant α-syn purified from E. coli showed an unstructured monomeric species (Weinreb et al., 1996). Endogenous α-syn extracted from neurons (M17D), HeLa, brain tissues, and human red blood cells was characterized dominantly as a tetramer featuring an α-helical bundle structure that were evidenced by multiple approaches including native PAGE, cross linking, transmission electron microscopy (TEM), scanning transmission electron microscopy (STEM) and sedimentation equilibrium analytical ultracentrifugation (SE-AUC; Chen et al., 2007; Bartels et al., 2011). However, following studies by other biophysical methods (e.g., light scattering and NMR) indicated that the “tetramer” species was actually a minority compared to dominant unstructured monomers (Binolfi et al., 2012; Burré et al., 2013; Gurry et al., 2013). Recently, Theillet et al. (2016) have shown that α-syn remains as a monomer by using in vivo NMR (Theillet et al., 2016). They transformed mammalian neuronal and non-neuronal cells with 15N labeled α-syn by electroporation, and found that most regions of α-syn remain unstructured with a high flexibility. An intriguing observation is that, the intensity of NMR signals of the N-terminal 10 residues and a few residues in the central and C-terminal regions of α-syn dropped dramatically, indicating an interaction between α-syn and some unidentified molecules in vivo (Theillet et al., 2016). Theillet et al. (2016) tested the interactions of Ficoll, BSA, lysozyme, and liposome with α-syn in vitro. However, none of them can fully resemble the in vivo observation. The controversial results of the structural studies on the native state of α-syn in cytosol suggest a significant morphological plasticity. It is plausible that the structure of α-syn in cytosol highly depends on its binding partners such as metabolites, lipids, and chaperones. The identification of these binding partners of α-syn in cytosol would be a notable step forward to understanding the physiological function of α-syn.
Polymorphic Structures of the Parkinson’S Associated α-Syn Amyloid Aggregation
Under certain conditions, α-syn spontaneously enters the amyloid state and self-assembles into amyloid oligomers and fibrils. Amyloid fibril of α-syn was identified as a prominent component of LB, a molecular hallmark of PD (Spillantini et al., 1997). It remains controversial whether the α-syn amyloids are the consequence or cause of PD. Therefore, structural understanding of α-syn amyloids is crucial to imply the cytotoxicity of the amyloid aggregates and to reveal the molecular mechanism of the disease. However, given the intrinsic instability and polymorphic nature of amyloid oligomers (Stroud et al., 2012; Gurry et al., 2013), and insolubility and heterogeneity of amyloid fibrils (Heise et al., 2005; Liu et al., 2012), it remains challenging to determine the atomic structures of full-length α-syn in either form.
Despite the difficulties, efforts have been made towards the atomic structures of α-syn fibrils by using different approaches. The fibril core was firstly mapped by proteinase K digestion of recombinant α-syn and α-syn extracted from synucleinopathic brains (Miake et al., 2002). The fibril core contains residues 31–109, covering the entire NAC region and part of the N- and C-terminal regions. The structural model of α-syn protofilament was calculated by the structural constraints derived from EPR (Der-Sarkissian et al., 2003; Chen et al., 2007) and solid-state NMR experiments (Heise et al., 2005; Vilar et al., 2008). This model comprises a five-layered β-sandwich, which generates five layers of parallel, in-register β-sheets as incorporated into a protofilament. Furthermore, protofilaments align with or twist around each other to form a fibril (Figure 1E, upper). This model sets up a starting point toward the structural understanding of α-syn amyloid aggregation.
Recently, micro-electron diffraction (MicroED) has been applied to the micro-sized and nano-sized crystals of amyloid-forming peptides. Atomic structures of the segments from α-syn fibril core, NACore (residues 68–78), and PreNAC (residues 47–56), were determined at 1.4 Å resolution (Rodriguez et al., 2015). The structure of NACore in the fibrillar form reveals a typical steric zipper spine structure featuring a high complimentary and dry interface formed by Thr and Ile of the two adjacent 11 mers (Figure 1F). Importantly, the NACore fibril resembles the cytotoxicity of the full-length α-syn fibril in the PC12 cells. Based on the atomic structures of NACore and PreNAC, a hypothetical model of α-syn fibril was built. In this model, each α-syn monomer forms an antiparallel β-sheet structure stabilized by a hetero-zipper-like interaction, and stacks on top of each other to form a protofilament (Figure 1E, middle). Two protofilaments are paired simultaneously by zipper-like interactions of residues V70, T72, V74, and A76 (Figure 1E, middle). The model explains the disease-related mutation A53T, which could form a tighter steric zipper interface so that stabilizes the toxic fibril structure. This is also in consistence with the highly aggregation-prone nature of A53T, which may gain higher resistance to degradation than the wildtype.
Another structural model of α-syn protofilament was proposed based on cryo-EM and dark-filed STEM studies (Dearborn et al., 2015). Each protofilament consists of two v-shaped β-serpentines formed by three antiparallel β-strands (Figure 1E, bottom). The entwined protofilaments may further assemble into mature fibrils. However, the resolution of the structural model is low (~30 Å) owing to the heterogeneity of the fibril samples. Detailed structural information is still beyond reach from this study. Most recently, a three-dimensional structural model of full-length α-syn fibril was determined by solid-state NMR and STEM, and validated by fibril diffraction (Figure 1G; Tuttle et al., 2016). The root-mean-square (RMS) deviation of the 10 lowest-energy structures of fibril core (residues 46–54 and 63–96) is 2.0 Å for all heavy atoms. The structure features a Greek-key topology which is entirely different from previous fibril structures. The fibril core is formed by parallel in-register β-sheets, and stabilized by hetero-steric zippers, salt-bridges, a glutamine ladder and hydrophobic interactions. Notably, the fibrils used in this structural study can induce aggregation of endogenous α-syn to form phosphorylated inclusions, and cause neuronal injury and death of primary hippocampal neurons. The follow-up study on structure-toxicity relationship will be valuable to elucidate the structural basis of α-syn fibril pathology.
The diverse structures of α-syn fibril support the polymorphic nature of α-syn fibrils formed under different conditions. Recently, two strains of α-syn fibrils with distinct morphologies were reported (Bousset et al., 2013). They exhibit different neurotoxicity and cell-to-cell transmission properties, and thus lead to distinct pathologies. Another study shows that α-syn is capable of cross-seeding the aggregation of tau protein, which is one of the main amyloid proteins in AD, in vivo (Guo et al., 2013). Notably, tau proteins cross-seeded by α-syn fibrils prepared from various protocols exhibit different properties and result in distinct histopathological and behavioral phenotypes in mice. Therefore, it would be valuable to link structural models of α-syn fibrils with their pathogenic counterparts, which may possibly imply the difference of the cellular effects, and bridge the gap between structures and neuronal toxicity.
The amyloid oligomers of α-syn were reported to cause cell death in cells and model systems such as C. elegans and Drosophila (Karpinar et al., 2009). In contrast to the fibrillar form of α-syn, the structural details of α-syn oligomers remain absent owing to their transient and labile properties. Several studies report that α-syn oligomers feature a β-rich structure with either parallel or antiparallel β-sheets. An annular channel-like architecture of oligomers formed by wild-type α-syn or A53T mutant was observed in the presence of lipid by atomic force microscopy (AFM; Figure 1H; Quist et al., 2005) and in solution by EM (Lashuel et al., 2002). It indicates that α-syn oligomers may poison cells by forming ion channels on the membrane or disrupting the membrane integrity. Through cryo-EM, another group characterized α-syn oligomer structures showing two types of annular oligomers in solution (Figure 1I; Chen et al., 2015). The cavity in these annular structures may accommodate substrates such as metals, fatty acids, and other small molecules. Interestingly, α-syn point mutations E35K and E57K, rather than A30P and E46K, prefer to form annular oligomers, are more prone to form fibrils, and exhibit potential neuronal toxicity in the rat substantia nigra (SN) region (Winner et al., 2011). Most recently, a label-free single molecular study revealed that lipids facilitate α-syn oligomerization without altering the aggregation pathway (Hu et al., 2016). These results together highlight the potential importance of annular oligomers in pathogenesis.
The research works summarized here show a rapid advance of our knowledge on α-syn functions and structures under physiological and pathogenic conditions (Figure 2). Meanwhile, several fundamental questions remain to be answered, such as the structural basis of α-syn conformational transition, the correlation between structural models and the cellular roles of α-syn, as well as unknown endogenous cofactors (e.g., metabolites, lipids, and chaperones) regulating the structural transformation of α-syn upon environmental changes. New technologies would be extremely helpful to address these questions. For example, integrating new imaging techniques with the current approaches of structural determination would allow a high resolution structural analysis of different α-syn structural species in test tubes, cells, and living tissues. Novel cellular and biochemical approaches are required to discover the endogenous molecules that interplay with different α-syn conformations. As the answers to these questions emerge, a clear picture of the physiological function and pathogenic behavior of α-syn will be within reach, which may further provide new molecular targets and drug candidates for therapeutic intervention against α-syn related diseases.
Figure 2. The schematics of different species of α-syn under physiological and pathogenic conditions. Monomeric α-syn induces vesicle clustering and chaperones soluble n-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembling via binding to the SNARE protein synaptobrevin-2/VAMP2 and membrane under the physiological condition. While, under the pathogenic condition, α-syn self-assembles into amyloid oligomers and fibrils. Different types of α-syn oligomers may impair vesicle association, and insert into the membrane by forming pore-like oligomers.
All authors wrote the article. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by the “1000 Talents” Program of China, the State High-Tech Development Plan (the “863 Program”) Award (Grant 2015AA020907), the National Natural Science Foundation (NSF) of China (Grant 31470748), the 973-program (2015CB856304).
Bodner, C. R., Dobson, C. M., and Bax, A. (2009). Multiple tight phospholipid-binding modes of α-synuclein revealed by solution NMR spectroscopy. J. Mol. Biol. 390, 775–790. doi: 10.1016/j.jmb.2009.05.066
Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., et al. (2013). Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4:2575. doi: 10.1038/ncomms3575
Brunger, A. T., Cipriano, D. J., and Diao, J. (2015). Towards reconstitution of membrane fusion mediated by SNAREs and other synaptic proteins. Crit. Rev. Biochem. Mol. Biol. 50, 231–241. doi: 10.3109/10409238.2015.1023252
Burré, J., Sharma, M., and Südhof, T. C. (2014). α-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U S A 111, E4274–E4283. doi: 10.1073/pnas.1416598111
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., and Südhof, T. C. (2010). α-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663–1667. doi: 10.1126/science.1195227
Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., and Südhof, T. C. (2005). Alpha-synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123, 383–396. doi: 10.1016/j.cell.2005.09.028
Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., et al. (2004). Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 1167–1169. doi: 10.1016/s0140-6736(04)17103-1
Chen, S. W., Drakulic, S., Deas, E., Ouberai, M., Aprile, F. A., Arranz, R., et al. (2015). Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc. Natl. Acad. Sci. U S A 112, E1994–E2003. doi: 10.1073/pnas.1421204112
Chen, M., Margittai, M., Chen, J., and Langen, R. (2007). Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J. Biol. Chem. 282, 24970–24979. doi: 10.1074/jbc.m700368200
Choi, B.-K., Choi, M.-G., Kim, J.-Y., Yang, Y., Lai, Y., Kweon, D.-H., et al. (2013). Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc. Natl. Acad. Sci. U S A 110, 4087–4092. doi: 10.1073/pnas.1218424110
Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998). Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443–9449. doi: 10.1074/jbc.273.16.9443
Dearborn, A. D., Wall, J. S., Cheng, N., Heymann, J. B., Kajava, A. V., Varkey, J., et al. (2015). α-synuclein amyloid fibrils with two entwined, asymmetrically associated, protofibrils. J. Biol. Chem. 291, 2310–2318. doi: 10.1074/jbc.273.16.9443
Der-Sarkissian, A., Jao, C. C., Chen, J., and Langen, R. (2003). Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 37530–37535. doi: 10.1074/jbc.M305266200
Diao, J., Burré, J., Vivona, S., Cipriano, D. J., Sharma, M., Kyoung, M., et al. (2013). Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2. Elife 2:e00592. doi: 10.7554/eLife.00592
Drescher, M., Godschalk, F., Veldhuis, G., Van Rooijen, B. D., Subramaniam, V., and Huber, M. (2008). Spin-Label EPR on α-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices. Chembiochem 9, 2411–2416. doi: 10.1002/cbic.200800238
Eliezer, D., Kutluay, E., Bussell, R. Jr., and Browne, G. (2001). Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061–1073. doi: 10.1006/jmbi.2001.4538
Fauvet, B., Mbefo, M. K., Fares, M.-B., Desobry, C., Michael, S., Ardah, M. T., et al. (2012). α-synuclein in central nervous system and from erythrocytes, mammalian cells and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 287, 15345–15364. doi: 10.1074/jbc.M111.318949
Ferese, R., Modugno, N., Campopiano, R., Santilli, M., Zampatti, S., Giardina, E., et al. (2015). Four copies of SNCA responsible for autosomal dominant Parkinson’s disease in two Italian siblings. Parkinsons Dis. 2015:546462. doi: 10.1155/2015/546462
Ferreon, A. C., Gambin, Y., Lemke, E. A., and Deniz, A. A. (2009). Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc. Natl. Acad. Sci. U S A 106, 5645–5650. doi: 10.1073/pnas.0809232106
Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., et al. (2014). Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat. Commun. 5:3827. doi: 10.1038/ncomms4827
George, J. M., Jin, H., Woods, W. S., and Clayton, D. F. (1995). Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361–372. doi: 10.1016/0896-6273(95)90040-3
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., et al. (2013). Distinct α-synuclein strains differentially promote Tau inclusions in neurons. Cell 154, 103–117. doi: 10.1016/j.cell.2013.05.057
Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., and Baldus, M. (2005). Molecular-level secondary structure, polymorphism and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc. Natl. Acad. Sci. U S A 102, 15871–15876. doi: 10.1073/pnas.0506109102
Hu, R., Diao, J., Li, J., Tang, Z., Li, X., Leitz, J., et al. (2016). Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores. Sci. Rep. 6:20776. doi: 10.1038/srep20776
Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. A., et al. (1995). The precursor protein of non-A beta component of Alzheimer’s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14, 467–475. doi: 10.1016/0896-6273(95)90302-x
Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., and Langen, R. (2008). Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement. Proc. Natl. Acad. Sci. U S A 105, 19666–19671. doi: 10.1073/pnas.0807826105
Karpinar, D. P., Balija, M. B. G., Kügler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., et al. (2009). Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson’s disease models. EMBO J. 28, 3256–3268. doi: 10.1038/emboj.2009.257
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., and Kösel, S. (1998). Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat. Genet. 18, 106–108. doi: 10.1038/ng0298-106
Lai, Y., Kim, S., Varkey, J., Lou, X., Song, J.-K., Diao, J., et al. (2014). Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding. Biochemistry 53, 3889–3896. doi: 10.1021/bi5002536
Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., et al. (2006). α-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915–11922. doi: 10.1523/JNEUROSCI.3821-06.2006
Lashuel, H. A., Overk, C. R., Oueslati, A., and Masliah, E. (2013). The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38–48. doi: 10.1038/nrn3406
Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., et al. (2013). G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–471. doi: 10.1002/ana.23894
Liu, C., Zhao, M., Jiang, L., Cheng, P.-N., Park, J., Sawaya, M. R., et al. (2012). Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates. Proc. Natl. Acad. Sci. U S A 109, 20913–20918. doi: 10.1073/pnas.1218792109
Marotta, N. P., Lin, Y. H., Lewis, Y. E., Ambroso, M. R., Zaro, B. W., Roth, M. T., et al. (2015). O-GlcNAc modification blocks the aggregation and toxicity of the Parkinson’s disease associated protein α-synuclein. Nat. Chem. 7, 913–920. doi: 10.1038/nchem.2361
Miake, H., Mizusawa, H., Iwatsubo, T., and Hasegawa, M. (2002). Biochemical characterization of the core structure of α-synuclein filaments. J. Biol. Chem. 277, 19213–19219. doi: 10.1074/jbc.M110551200
Mizuno, N., Varkey, J., Kegulian, N. C., Hegde, B. G., Cheng, N., Langen, R., et al. (2012). Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation. J. Biol. Chem. 287, 29301–29311. doi: 10.1074/jbc.M112.365817
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., et al. (2010). Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66–79. doi: 10.1016/j.neuron.2009.12.023
Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H., Lamberto, G. R., et al. (2014). Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization and influences synuclein-membrane interactions. J. Neurosci. 30, 3184–3198. doi: 10.1523/JNEUROSCI.5922-09.2010
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., et al. (2014). A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol. Aging 35, 2180.e1–2180.e5. doi: 10.1016/j.neurobiolaging.2014.03.024
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047. doi: 10.1126/science.276.5321.2045
Proukakis, C., Dudzik, C. G., Brier, T., MacKay, D. S., Cooper, J. M., Millhauser, G. L., et al. (2013). A novel α-synuclein missense mutation in Parkinson disease. Neurology 80, 1062–1064. doi: 10.1212/WNL.0b013e31828727ba
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., et al. (2005). Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U S A 102, 10427–10432. doi: 10.1073/pnas.0502066102
Rao, J. N., Jao, C. C., Hegde, B. G., Langen, R., and Ulmer, T. S. (2010). A combinatorial NMR and EPR approach for evaluating the structural ensemble of partially folded proteins. J. Am. Chem. Soc. 132, 8657–8668. doi: 10.1021/ja100646t
Robotta, M., Braun, P., Van Rooijen, B., Subramaniam, V., Huber, M., and Drescher, M. (2011). Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein. Chemphyschem 12, 267–269. doi: 10.1002/cphc.201000815
Rodriguez, J. A., Ivanova, M. I., Sawaya, M. R., Cascio, D., Reyes, F. E., Shi, D., et al. (2015). Structure of the toxic core of α-synuclein from invisible crystals. Nature 525, 486–490. doi: 10.1038/nature15368
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302:841. doi: 10.1126/science.1090278
Theillet, F. X., Binolfi, A., Bekei, B., Martorana, A., Rose, H. M., Stuiver, M., et al. (2016). Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature 530, 45–50. doi: 10.1038/nature16531
Tuttle, M. D., Comellas, G., Nieuwkoop, A. J., Covell, D. J., Berthold, D. A., Kloepper, K. D., et al. (2016). Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23, 409–415. doi: 10.1038/nsmb.3194
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., et al. (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U S A 90, 11282–11286. doi: 10.1073/pnas.90.23.11282
Uversky, V. N., Li, J., and Fink, A. L. (2001). Metal-triggered structural transformations, aggregation and fibrillation of human α-synuclein. A possible molecular link between Parkinson’s disease and heavy metal exposure. J. Biol. Chem. 276, 44284–44296. doi: 10.1074/jbc.M105343200
Wang, L., Das, U., Scott, D. A., Tang, Y., McLean, P. J., and Roy, S. (2014). Alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319–2326. doi: 10.1016/j.cub.2014.08.027
Weinreb, P. H., Zhen, W., Poon, A. W., Conway, K. A., and Lansbury, P. T. (1996). NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry 35, 13709–13715. doi: 10.1021/bi961799n
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., et al. (2011). In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U S A 108, 4194–4199. doi: 10.1073/pnas.1100976108
Keywords: α-synuclein, Parkinson’s disease, amyloid, atomic structure, vesicle trafficking, protein aggregation
Citation: Wang C, Zhao C, Li D, Tian Z, Lai Y, Diao J and Liu C (2016) Versatile Structures of α-Synuclein. Front. Mol. Neurosci. 9:48. doi: 10.3389/fnmol.2016.00048
Received: 11 April 2016; Accepted: 06 June 2016;
Published: 20 June 2016.
Edited by:Nashat Abumaria, Fudan University, China
Reviewed by:Mohiuddin Ahmad, University of Oklahoma Health Sciences Center, USA
Kai Zhang, University of Illinois at Urbana-Champaign, USA
Copyright © 2016 Wang, Zhao, Li, Tian, Lai, Diao and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.